Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASPHYLAX: Intermittent Caspofungin Prophylaxis
NCT01318148Phase 2Completed
- Start
- Apr 2011
- Primary completion
- Sep 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caspofungin in invasive fungal disease (IFD). Started Apr 2011; status: completed.
02
Drugs
caspofungin
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT01318148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318148.